{"id":"W1825587443","doi":"10.1002/14651858.cd008870.pub2","title":"Aminosalicylates for induction of remission or response in Crohn's disease","year":2016,"lang":"en","type":"review","venue":"Cochrane Database of Systematic Reviews","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":240,"is_retracted":false,"has_abstract":true,"ca_institutions":"Cochrane; Robarts Clinical Trials; Western University","funders":"","keywords":"Medicine; Sulfasalazine; Internal medicine; Placebo; Adverse effect; Crohn's disease; Randomized controlled trial; Cochrane Library; Meta-analysis; MEDLINE; Clinical endpoint; Relative risk; Disease; Confidence interval; Alternative medicine; Ulcerative colitis; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high","status":"direct model label, unvalidated"}],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02684866,0.001304971,0.0117794,0.006987485,0.0005818554,0.002940658,0.001845163,0.003022262,0.005534569],"category_scores_gemma":[0.07363627,0.0006954608,0.009986379,0.005358984,0.001695209,0.002113468,0.001211186,0.002099835,0.0003294189],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003836081,"about_ca_system_score_gemma":0.006325216,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002746623,"about_ca_topic_score_gemma":0.004724179,"domain_scores_codex":[0.9661621,0.01762699,0.01084711,0.001600444,0.003401336,0.0003619372],"domain_scores_gemma":[0.9253505,0.05331598,0.01800913,0.0006178443,0.002214406,0.0004921379],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.003107751,0.00004492588,0.0008353875,0.9340902,0.01291594,0.00006262446,0.0001047225,0.0001236355,0.0001507009,0.0003537697,0.001076898,0.04713346],"study_design_scores_gemma":[0.01618944,0.003431685,0.008417627,0.8428665,0.1089548,0.000453573,0.0002725605,0.0003114871,0.000611587,0.001510093,0.01688993,0.00009074808],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001605145,0.9967569,0.0001136154,0.0003077849,0.0001839907,0.0005668296,0.0001430042,0.000006970328,0.0003158263],"genre_scores_gemma":[0.0660349,0.925905,0.002252853,0.001684454,0.0005917368,0.002905904,0.0003409826,0.00001193117,0.0002722411],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.02684866,"threshold_uncertainty_score":0.141991,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08052863481039342,"score_gpt":0.3835047148438523,"score_spread":0.3029760800334589,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}